Skip to main content
Top
Published in: Abdominal Radiology 2/2017

01-02-2017 | Pictorial Essay

An overview of PET/MR, focused on clinical applications

Authors: Onofrio Antonio Catalano, William Roger Masch, Ciprian Catana, Umar Mahmood, Dushyant Vasudeo Sahani, Michael Stanley Gee, Leon Menezes, Andrea Soricelli, Marco Salvatore, Debra Gervais, Bruce Robert Rosen

Published in: Abdominal Radiology | Issue 2/2017

Login to get access

Abstract

Hybrid PET/MR scanners are innovative imaging devices that simultaneously or sequentially acquire and fuse anatomical and functional data from magnetic resonance (MR) with metabolic information from positron emission tomography (PET) (Delso et al. in J Nucl Med 52:1914–1922, 2011; Zaidi et al. in Phys Med Biol 56:3091–3106, 2011). Hybrid PET/MR scanners have the potential to greatly impact not only on medical research but also, and more importantly, on patient management. Although their clinical applications are still under investigation, the increased worldwide availability of PET/MR scanners, and the growing published literature are important determinants in their rising utilization for primarily clinical applications. In this manuscript, we provide a summary of the physical features of PET/MR, including its limitations, which are most relevant to clinical PET/MR implementation and to interpretation. Thereafter, we discuss the most important current and emergent clinical applications of such hybrid technology in the abdomen and pelvis, both in the field of oncologic and non-oncologic imaging, and we provide, when possible, a comparison with clinically consolidated imaging techniques, like for example PET/CT.
Literature
1.
go back to reference Delso G, Furst S, Jakoby B, et al. (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922CrossRefPubMed Delso G, Furst S, Jakoby B, et al. (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922CrossRefPubMed
2.
3.
go back to reference Torigian DA, Zaidi H, Kwee TC, et al. (2013) PET/MR imaging: technical aspects and potential clinical applications. Radiology 267:26–44CrossRefPubMed Torigian DA, Zaidi H, Kwee TC, et al. (2013) PET/MR imaging: technical aspects and potential clinical applications. Radiology 267:26–44CrossRefPubMed
5.
go back to reference Hofmann M, Bezrukov I, Mantlik F, et al. (2011) MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods. J Nucl Med 52:1392–1399CrossRefPubMed Hofmann M, Bezrukov I, Mantlik F, et al. (2011) MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods. J Nucl Med 52:1392–1399CrossRefPubMed
6.
go back to reference Dickson JC, O’Meara C, Barnes A (2014) A comparison of CT- and MR-based attenuation correction in neurological PET. Eur J Nucl Med Mol Imaging 41:1176–1189CrossRefPubMed Dickson JC, O’Meara C, Barnes A (2014) A comparison of CT- and MR-based attenuation correction in neurological PET. Eur J Nucl Med Mol Imaging 41:1176–1189CrossRefPubMed
7.
go back to reference Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med 53:1916–1925CrossRefPubMed Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med 53:1916–1925CrossRefPubMed
9.
go back to reference Antoch G, Stattaus J, Nemat AT, et al. (2003) Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526–533CrossRefPubMed Antoch G, Stattaus J, Nemat AT, et al. (2003) Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526–533CrossRefPubMed
10.
go back to reference Lardinois D, Weder W, Hany TF, et al. (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507CrossRefPubMed Lardinois D, Weder W, Hany TF, et al. (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507CrossRefPubMed
11.
go back to reference Boss DS, Olmos RV, Sinaasappel M, Beijnen JH, Schellens JH (2008) Application of PET/CT in the development of novel anticancer drugs. Oncologist 13:25–38CrossRefPubMed Boss DS, Olmos RV, Sinaasappel M, Beijnen JH, Schellens JH (2008) Application of PET/CT in the development of novel anticancer drugs. Oncologist 13:25–38CrossRefPubMed
12.
13.
go back to reference Jerusalem G, Beguin Y, Najjar F, et al. (2001) Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL). Ann Oncol 12:825–830CrossRefPubMed Jerusalem G, Beguin Y, Najjar F, et al. (2001) Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL). Ann Oncol 12:825–830CrossRefPubMed
14.
go back to reference Kayani I, Bomanji JB, Groves A, et al. (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68 Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112:2447–2455CrossRefPubMed Kayani I, Bomanji JB, Groves A, et al. (2008) Functional imaging of neuroendocrine tumors with combined PET/CT using 68 Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer 112:2447–2455CrossRefPubMed
15.
go back to reference Park JW, Kim JH, Kim SK, et al. (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921CrossRefPubMed Park JW, Kim JH, Kim SK, et al. (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921CrossRefPubMed
16.
go back to reference Son H, Khan SM, Rahaman J, et al. (2011) Role of FDG PET/CT in staging of recurrent ovarian cancer. Radiographics 31:569–583CrossRefPubMed Son H, Khan SM, Rahaman J, et al. (2011) Role of FDG PET/CT in staging of recurrent ovarian cancer. Radiographics 31:569–583CrossRefPubMed
17.
go back to reference Mueller-Lisse UG, Mueller-Lisse UL, Meindl T, et al. (2007) Staging of renal cell carcinoma. Eur Radiol 17:2268–2277CrossRefPubMed Mueller-Lisse UG, Mueller-Lisse UL, Meindl T, et al. (2007) Staging of renal cell carcinoma. Eur Radiol 17:2268–2277CrossRefPubMed
18.
go back to reference Ozawa Y, Hara M, Sakurai K, et al. (2010) Diagnostic accuracy of (18)F-2-deoxy-fluoro-d-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Acta Radiol 51:150–155CrossRefPubMed Ozawa Y, Hara M, Sakurai K, et al. (2010) Diagnostic accuracy of (18)F-2-deoxy-fluoro-d-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Acta Radiol 51:150–155CrossRefPubMed
19.
go back to reference Sharma P, Kumar R, Singh H, et al. (2012) Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence. Clin Nucl Med 37:649–655CrossRefPubMed Sharma P, Kumar R, Singh H, et al. (2012) Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence. Clin Nucl Med 37:649–655CrossRefPubMed
20.
go back to reference von Schulthess GK, Schlemmer HP (2009) A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 36(Suppl 1):S3–S9CrossRef von Schulthess GK, Schlemmer HP (2009) A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 36(Suppl 1):S3–S9CrossRef
21.
go back to reference Nasu K, Kuroki Y, Nawano S, et al. (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239:122–130CrossRefPubMed Nasu K, Kuroki Y, Nawano S, et al. (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239:122–130CrossRefPubMed
22.
go back to reference Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718CrossRefPubMed Padhani AR, Koh DM, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718CrossRefPubMed
23.
go back to reference Brown G, Richards CJ, Bourne MW, et al. (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227:371–377CrossRefPubMed Brown G, Richards CJ, Bourne MW, et al. (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227:371–377CrossRefPubMed
24.
go back to reference Bruegel M, Holzapfel K, Gaa J, et al. (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477–485CrossRefPubMed Bruegel M, Holzapfel K, Gaa J, et al. (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477–485CrossRefPubMed
25.
go back to reference Eiber M, Beer AJ, Holzapfel K, et al. (2010) Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 45:15–23CrossRefPubMed Eiber M, Beer AJ, Holzapfel K, et al. (2010) Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 45:15–23CrossRefPubMed
26.
go back to reference Fornasa F, Nesoti MV, Bovo C, Bonavina MG (2012) Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer. J Magn Reson Imaging 36:858–864CrossRefPubMed Fornasa F, Nesoti MV, Bovo C, Bonavina MG (2012) Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer. J Magn Reson Imaging 36:858–864CrossRefPubMed
27.
go back to reference De Iaco P, Musto A, Orazi L, et al. (2011) FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. Eur J Radiol 80:e98–e103CrossRefPubMed De Iaco P, Musto A, Orazi L, et al. (2011) FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. Eur J Radiol 80:e98–e103CrossRefPubMed
28.
go back to reference Soussan M, Des Guetz G, Barrau V, et al. (2012) Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Eur Radiol 22:1479–1487CrossRefPubMed Soussan M, Des Guetz G, Barrau V, et al. (2012) Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Eur Radiol 22:1479–1487CrossRefPubMed
29.
go back to reference De Gaetano AM, Calcagni ML, Rufini V, et al. (2009) Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls. Abdom Imaging 34:391–402CrossRefPubMed De Gaetano AM, Calcagni ML, Rufini V, et al. (2009) Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls. Abdom Imaging 34:391–402CrossRefPubMed
30.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed
31.
go back to reference Kirchner J, Kirchner EM, Goltz JP, Lorenz VW, Kickuth R (2011) Prevalence of enlarged mediastinal lymph nodes in heavy smokers–a comparative study. Eur Radiol 21:1594–1599CrossRefPubMed Kirchner J, Kirchner EM, Goltz JP, Lorenz VW, Kickuth R (2011) Prevalence of enlarged mediastinal lymph nodes in heavy smokers–a comparative study. Eur Radiol 21:1594–1599CrossRefPubMed
32.
go back to reference Atkinson W, Catana C, Abramson JS, et al. (2016) Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdom Radiol 41:1338–1348CrossRef Atkinson W, Catana C, Abramson JS, et al. (2016) Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdom Radiol 41:1338–1348CrossRef
33.
go back to reference Heacock L, Weissbrot J, Raad R, et al. (2015) PET/MRI for the evaluation of patients with lymphoma: initial observations. Am J Roentgenol 204:842–848CrossRef Heacock L, Weissbrot J, Raad R, et al. (2015) PET/MRI for the evaluation of patients with lymphoma: initial observations. Am J Roentgenol 204:842–848CrossRef
34.
go back to reference Ponisio MR, McConathy J, Laforest R, Khanna G (2016) Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatric Radiol 46:1258–1268CrossRef Ponisio MR, McConathy J, Laforest R, Khanna G (2016) Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatric Radiol 46:1258–1268CrossRef
35.
go back to reference Park JM, Kim IY, Kim SW, et al. (2013) A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location. Ann Nucl Med 27:217–224CrossRefPubMed Park JM, Kim IY, Kim SW, et al. (2013) A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location. Ann Nucl Med 27:217–224CrossRefPubMed
36.
go back to reference Holalkere NS, Sahani DV, Blake MA, et al. (2006) Characterization of small liver lesions: Added role of MR after MDCT. J Comput Assist Tomogr 30:591–596CrossRefPubMed Holalkere NS, Sahani DV, Blake MA, et al. (2006) Characterization of small liver lesions: Added role of MR after MDCT. J Comput Assist Tomogr 30:591–596CrossRefPubMed
37.
go back to reference Barker DW, Zagoria RJ, Morton KA, Kavanagh PV, Shen P (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. Am J Roentgenol 184:1096–1102CrossRef Barker DW, Zagoria RJ, Morton KA, Kavanagh PV, Shen P (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. Am J Roentgenol 184:1096–1102CrossRef
38.
go back to reference Kamholtz R, Sze G (1991) Current imaging in spinal metastatic disease. Semin Oncol 18:158–169PubMed Kamholtz R, Sze G (1991) Current imaging in spinal metastatic disease. Semin Oncol 18:158–169PubMed
39.
go back to reference Nakai T, Okuyama C, Kubota T, et al. (2005) Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 32:1253–1258CrossRefPubMed Nakai T, Okuyama C, Kubota T, et al. (2005) Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 32:1253–1258CrossRefPubMed
40.
go back to reference Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942–2953CrossRefPubMed Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942–2953CrossRefPubMed
41.
go back to reference Sugawara Y, Fisher SJ, Zasadny KR, et al. (1998) Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16:173–180CrossRefPubMed Sugawara Y, Fisher SJ, Zasadny KR, et al. (1998) Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16:173–180CrossRefPubMed
42.
go back to reference Even-Sapir E, Metser U, Flusser G, et al. (2004) Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 45:272–278PubMed Even-Sapir E, Metser U, Flusser G, et al. (2004) Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 45:272–278PubMed
43.
go back to reference Damle NA, Bal C, Bandopadhyaya GP, et al. (2013) The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99 mTc-MDP bone scan. Jpn J Radiol 31:262–269CrossRefPubMed Damle NA, Bal C, Bandopadhyaya GP, et al. (2013) The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99 mTc-MDP bone scan. Jpn J Radiol 31:262–269CrossRefPubMed
44.
45.
go back to reference Lecouvet FE, El Mouedden J, Collette L, et al. (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62:68–75CrossRefPubMed Lecouvet FE, El Mouedden J, Collette L, et al. (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62:68–75CrossRefPubMed
46.
go back to reference Ferraro R, Agarwal A, Martin-Macintosh EL, Peller PJ, Subramaniam RM (2015) MR imaging and PET/CT in diagnosis and management of multiple myeloma. Radiographics 35:438–454CrossRefPubMed Ferraro R, Agarwal A, Martin-Macintosh EL, Peller PJ, Subramaniam RM (2015) MR imaging and PET/CT in diagnosis and management of multiple myeloma. Radiographics 35:438–454CrossRefPubMed
47.
go back to reference Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI (1994) Multiple myeloma: MR patterns of response to treatment. Radiology 193:441–446CrossRefPubMed Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI (1994) Multiple myeloma: MR patterns of response to treatment. Radiology 193:441–446CrossRefPubMed
48.
go back to reference Agarwal A, Chirindel A, Shah BA, Subramaniam RM (2013) Evolving role of FDG PET/CT in multiple myeloma imaging and management. Am J Roentgenol 200:884–890CrossRef Agarwal A, Chirindel A, Shah BA, Subramaniam RM (2013) Evolving role of FDG PET/CT in multiple myeloma imaging and management. Am J Roentgenol 200:884–890CrossRef
49.
go back to reference Schoder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274–292CrossRefPubMed Schoder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274–292CrossRefPubMed
50.
go back to reference Kim DJ, Kim JH, Ryu YH, et al. (2011) Nodal staging of rectal cancer: high-resolution pelvic MRI versus (1)(8)F-FDGPET/CT. J Comput Assist Tomogr 35:531–534CrossRefPubMed Kim DJ, Kim JH, Ryu YH, et al. (2011) Nodal staging of rectal cancer: high-resolution pelvic MRI versus (1)(8)F-FDGPET/CT. J Comput Assist Tomogr 35:531–534CrossRefPubMed
51.
go back to reference Kim SH, Choi BI, Han JK, et al. (1993) Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 17:633–640CrossRefPubMed Kim SH, Choi BI, Han JK, et al. (1993) Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J Comput Assist Tomogr 17:633–640CrossRefPubMed
52.
go back to reference Kim DJ, Kim JH, Lim JS, et al. (2010) Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 30:503–516CrossRefPubMed Kim DJ, Kim JH, Lim JS, et al. (2010) Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 30:503–516CrossRefPubMed
53.
go back to reference Stolzmann P, Veit-Haibach P, Chuck N, et al. (2013) Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Invest Radiol 48:241–246CrossRefPubMed Stolzmann P, Veit-Haibach P, Chuck N, et al. (2013) Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Invest Radiol 48:241–246CrossRefPubMed
54.
go back to reference Catalano OA, Rosen BR, Sahani DV, et al. (2013) Clinical impact of PET/mr imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients—a hypothesis-generating exploratory study. Radiology 269(3):857–8692013CrossRefPubMed Catalano OA, Rosen BR, Sahani DV, et al. (2013) Clinical impact of PET/mr imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients—a hypothesis-generating exploratory study. Radiology 269(3):857–8692013CrossRefPubMed
55.
go back to reference Hirsch FW, Sattler B, Sorge I, et al. (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43:860–875CrossRefPubMedPubMedCentral Hirsch FW, Sattler B, Sorge I, et al. (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43:860–875CrossRefPubMedPubMedCentral
56.
go back to reference Schafer JF, Gatidis S, Schmidt H, et al. (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231CrossRefPubMed Schafer JF, Gatidis S, Schmidt H, et al. (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231CrossRefPubMed
57.
go back to reference Pugmire BS, Guimaraes AR, Lim R, et al. (2016) Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography. World J Radiol 8:322–330CrossRefPubMedPubMedCentral Pugmire BS, Guimaraes AR, Lim R, et al. (2016) Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography. World J Radiol 8:322–330CrossRefPubMedPubMedCentral
58.
go back to reference Miglioretti DL, Johnson E, Williams A, et al. (2013) The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr 167:700–707CrossRefPubMedPubMedCentral Miglioretti DL, Johnson E, Williams A, et al. (2013) The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr 167:700–707CrossRefPubMedPubMedCentral
59.
go back to reference Shinagare AB, Sahni VA, Sadow CA, Erturk SM, Silverman SG (2011) Feasibility of low-tube-voltage excretory phase images during CT urography: assessment using a dual-energy CT scanner. Am J Roentgenol 197:1146–1151CrossRef Shinagare AB, Sahni VA, Sadow CA, Erturk SM, Silverman SG (2011) Feasibility of low-tube-voltage excretory phase images during CT urography: assessment using a dual-energy CT scanner. Am J Roentgenol 197:1146–1151CrossRef
60.
go back to reference Catalano OA, Gee MS, Nicolai E, et al. (2016) Evaluation of quantitative PET/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in crohn disease. Radiology 278:792–800CrossRefPubMed Catalano OA, Gee MS, Nicolai E, et al. (2016) Evaluation of quantitative PET/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in crohn disease. Radiology 278:792–800CrossRefPubMed
61.
go back to reference Pellino G, Nicolai E, Catalano OA, et al. (2016) PET/MR versus PET/CT imaging: impact on the clinical management of small-bowel Crohn’s disease. J Crohns Colitis 10:277–285CrossRefPubMed Pellino G, Nicolai E, Catalano OA, et al. (2016) PET/MR versus PET/CT imaging: impact on the clinical management of small-bowel Crohn’s disease. J Crohns Colitis 10:277–285CrossRefPubMed
Metadata
Title
An overview of PET/MR, focused on clinical applications
Authors
Onofrio Antonio Catalano
William Roger Masch
Ciprian Catana
Umar Mahmood
Dushyant Vasudeo Sahani
Michael Stanley Gee
Leon Menezes
Andrea Soricelli
Marco Salvatore
Debra Gervais
Bruce Robert Rosen
Publication date
01-02-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0894-5

Other articles of this Issue 2/2017

Abdominal Radiology 2/2017 Go to the issue

Classics in Abdominal Imaging

The leaping dolphin sign